SDI Labs was founded in 1987 by two molecular cytogeneticists from UCLA. In 2014, the company received significant financial backing and added highly skilled IT leaders. As a result, SDI Labs expanded their focus to molecular diagnostics of infectious diseases, women’s health, and autoimmune and mental health diagnostics. By adding deep software development expertise, SDI Labs has been able to leverage data science and automation to develop data-driven pathogen detection testing for various infectious diseases.
SDI SARS-CoV-2 Assay - EUA 4/2020